Literature DB >> 20152227

Intracoronary thrombus formation after drug-eluting stents implantation: optical coherence tomographic study.

Jung-Sun Kim1, Myeong-Ki Hong, Chunyu Fan, Tae-Hoon Kim, Jae-Min Shim, Sang-Min Park, Young-Guk Ko, Donghoon Choi, Yangsoo Jang.   

Abstract

BACKGROUND: Intracoronary thrombus formation after drug-eluting stent (DES) implantation is not sufficiently evaluated.
METHODS: Optical coherence tomography (OCT) was performed in 226 patients (total DES n = 244, sirolimus-eluting stent [SES] n = 95, paclitaxel-eluting stent [PES] n = 62, zotarolimus-eluting stent [ZES] n = 87) after implantation (mean 11 months, range 3-66 months). Using OCT, we investigated the incidence and determinants of intracoronary thrombus.
RESULTS: Intracoronary thrombus was detected in 35 (14%) cases (27 SES [28%], 7 PES [11%], and 1 ZES [1%], P < .001) and was associated with longer stent, smaller stent diameter, and stents at bifurcation lesions. More uncovered stent struts (26 +/- 23 vs 8 +/- 17, P < .001) and malapposed stent struts (6 +/- 14 vs 2 +/- 6, P < .001) were also associated with intracoronary thrombus. Multiple logistic regression analysis found the following determinants of intracoronary thrombus: stent length > or =28 mm (odds ratio [OR] 7.31, 95% CI 1.79-29.86, P = .01), stent diameter <3.0 mm (OR 4.38, 95% CI 1.38-13.97, P = .01), and > or =8 uncovered struts in each stent (OR 3.29, 95% CI 1.07-10.17, P = .04).
CONCLUSIONS: Length, size, and types of DES may be more important than clinical factors in intracoronary thrombus formation after DES implantations. Copyright (c) 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20152227     DOI: 10.1016/j.ahj.2009.11.029

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  13 in total

1.  Optical coherence tomography-based evaluation of malapposed strut coverage after drug-eluting stent implantation.

Authors:  Byeong-Keuk Kim; Dong-Ho Shin; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Int J Cardiovasc Imaging       Date:  2012-03-25       Impact factor: 2.357

2.  Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial.

Authors:  Pasi Karjalainen; Tuomas O Kiviniemi; Tuomas Lehtinen; Wail Nammas; Antti Ylitalo; Antti Saraste; Jussi Mikkelsson; Mikko Pietila; Fausto Biancari; Juhani K E Airaksinen
Journal:  Int J Cardiovasc Imaging       Date:  2013-08-31       Impact factor: 2.357

3.  Major determinants for the uncovered stent struts on optical coherence tomography after drug-eluting stent implantation.

Authors:  Byeong-Keuk Kim; Jung-Sun Kim; Changmyung Oh; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Int J Cardiovasc Imaging       Date:  2011-05-31       Impact factor: 2.357

4.  Optical coherence tomographic comparison of neointimal coverage between sirolimus- and resolute zotarolimus-eluting stents at 9 months after stent implantation.

Authors:  Jung-Sun Kim; Jin-Sun Kim; Dong-Ho Shin; Byeong-Keuk Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Int J Cardiovasc Imaging       Date:  2011-08-21       Impact factor: 2.357

5.  Correlation of angiographic late loss with neointimal coverage of drug-eluting stent struts on follow-up optical coherence tomography.

Authors:  Byeong-Keuk Kim; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Int J Cardiovasc Imaging       Date:  2011-08-24       Impact factor: 2.357

6.  Evaluation of neointimal morphology of lesions with or without in-stent restenosis: an optical coherence tomography study.

Authors:  Sung-Joo Lee; Byeong-Keuk Kim; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Clin Cardiol       Date:  2011-09-16       Impact factor: 2.882

7.  Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study.

Authors:  Tuomas Lehtinen; K E Juhani Airaksinen; Antti Ylitalo; Pasi P Karjalainen
Journal:  Int J Cardiovasc Imaging       Date:  2012-02-24       Impact factor: 2.357

8.  Optical coherence tomography derived cut-off value of uncovered stent struts to predict adverse clinical outcomes after drug-eluting stent implantation.

Authors:  Hoyoun Won; Dong-Ho Shin; Byeong-Keuk Kim; Gary S Mintz; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Int J Cardiovasc Imaging       Date:  2013-04-25       Impact factor: 2.357

9.  Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation.

Authors:  Young-Guk Ko; Dong-Min Kim; Jin Man Cho; So Yeon Choi; Jung Han Yoon; Jung-Sun Kim; Byeong-Keuk Kim; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Int J Cardiovasc Imaging       Date:  2011-06-08       Impact factor: 2.357

10.  Time-dependent conformational changes in adsorbed albumin and its effect on platelet adhesion.

Authors:  Balakrishnan Sivaraman; Robert A Latour
Journal:  Langmuir       Date:  2012-01-17       Impact factor: 3.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.